Table 1: Baseline characteristics
Variable | Frequency (n=1022) |
Sex Female Male F:M ratio |
n (%) 658 (64.4) 364 (35.6) 1.8:1 |
Age Mean (SD) Range |
Years 37.8 (10.0) 18-77 |
Initial WHO stage, I II III IV |
n (%) 249 (24.4) 299 (29.2) 326 (31.9) 148 (14.5) |
CD4+ at initiation of therapy Median (IQR) |
cells/mm3 149 (55-248) |
CD4+ at initiation < 100 100-200 >200 |
n (%) 377 (36.9) 273 (26.7) 372 (36.3) |